Evidence map›Paper›PMID 41859605›Full record

ArticleCureus2026

Surgical Management of Giant Basal Cell Carcinoma of the Upper Eyelid: A Case Report.

Swatishree Nayak, Sumanjit Boro, Bifica Lyndogh

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Swatishree NayakOphthalmology, All India Institute of Medical Sciences, Guwahati, IND.
Sumanjit BoroPlastic Surgery, All India Institute of Medical Sciences, Guwahati, IND.
Bifica LyndoghPathology, All India Institute of Medical Sciences, Guwahati, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basal cell carcinoma is the most common malignant tumor of the eyelid and, although typically slow growing, can become locally aggressive and disfiguring when diagnosis or treatment is delayed. We report a rare case of a giant, long-standing basal cell carcinoma of the upper eyelid in a 62-year-old female who presented with a 30-year history of a progressively enlarging pigmented ulcerative lesion associated with mechanical ptosis. Clinical examination revealed a large indurated ulcer with rolled margins involving the upper eyelid and eyebrow region, with no regional lymphadenopathy. Excisional biopsy followed by histopathological evaluation confirmed an infiltrative variant of basal cell carcinoma. The patient underwent wide local excision with adequate safety margins and immediate reconstruction using a forehead axial flap, with the donor site covered by a split-thickness skin graft. Postoperative recovery was uneventful, with good graft uptake and satisfactory functional and cosmetic outcomes at follow-up. This case highlights the potential for basal cell carcinoma to attain giant proportions when neglected, underscores the importance of histopathological confirmation and margin-controlled excision, and demonstrates that even extensive periocular tumors can be successfully managed with appropriate surgical planning and multidisciplinary reconstruction.

Indexed as

basal cell carcinomaeyelid reconstructioninfiltrativesurgical managementulcerative

Identifiers

PMID41859605
PMCPMC12995841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.